Arkolith/Insider Trading/LFCR/Form 4

Josephs Paul

Chief Executive Officer, DirectorLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) · full profile →Form 4 · filed Jan 8, 2025
Net Buying
Open-Market Buys
$98K
Open-Market Sells
$0
Net Open-Market Flow
$98K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2025Buy(P)17K$5.74$98K560K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-000943) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML